Thursday, December 19, 2024
HomeTagsMimiVax

MimiVax

MimiVax Announces Positive Final Data from the Phase IIa Study of SurVaxM

MimiVax is pleased to announce the published manuscript of the now completed Phase IIa study of SurVaxM, a cancer vaccine, in newly diagnosed glioblastoma...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics